Related references
Note: Only part of the references are listed.Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization
Kazuma Oyama et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Preventing treatment failures in coronary artery disease: what can we learn from the biology of in-stent restenosis, vein graft failure, and internal thoracic arteries?
Cristiano Spadaccio et al.
CARDIOVASCULAR RESEARCH (2020)
Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome
Benjamin M. Scirica et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Temporal Trends in Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: Insights From the Washington Cardiac Care Outcomes Assessment Program
Akash Kataruka et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Effect of Evolocumab on Atherogenic Lipoproteins During the Peri- and Early Postinfarction Period A Placebo-Controlled, Randomized Trial
Thorsten M. Leucker et al.
CIRCULATION (2020)
Low-Density Lipoprotein Cholesterol and Adverse Cardiovascular Events After Percutaneous Coronary Intervention
Maneesh Sud et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Trends in Characteristics and Outcomes of Patients Undergoing Coronary Revascularization in the United States, 2003-2016
Mohamad Alkhouli et al.
JAMA NETWORK OPEN (2020)
Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial
Patrick W. Serruys et al.
EUROPEAN HEART JOURNAL (2019)
Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)
Konstantinos C. Koskinas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
Karen A. Hicks et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Trends in US Cardiovascular Care 2016 Report From 4 ACC National Cardiovascular Data Registries
Frederick A. Masoudi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
Marc S. Sabatine et al.
AMERICAN HEART JOURNAL (2016)
Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial
Manel Sabate et al.
LANCET (2016)
Underutilization of High-Intensity Statin Therapy After Hospitalization for Coronary Heart Disease
Robert S. Rosenson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Targeting the Proprotein Convertase Subtilisin/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis
Daniel Urban et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Drug-Eluting Coronary-Artery Stents
Giulio G. Stefanini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Effect of Intensive Statin Therapy on Clinical Outcomes Among Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy
C. Michael Gibson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Comparison of Effectiveness of Atorvastatin 10 mg Versus 80 mg in Reducing Major Cardiovascular Events and Repeat Revascularization in Patients With Previous Percutaneous Coronary Intervention (Post Hoc Analysis of the Treating to New Targets [TNT] Study)
Colleen Johnson et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention - A randomized controlled trial
PWJC Serruys et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
